CGT

116개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved116 programs
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

ssCART-19 (ssCART-19)

B Cell Lymphoma · B Cell Lymphoma

#BCellLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 5Status Recruiting
CGTLimited DatastaleNational Heart, Lung, and Blood…Phase 2

Lentiviral G1XCGD Gene Therapy (Lentiviral G1XCGD Gene Therapy)

Granulomatous Disease, Chronic, X-linked · Granulomatous Disease, Chronic, X-linked

#GranulomatousDiseaseChronicX-lin#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 4Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CART22-65s cells (CART22-65s cells)

Chemotherapy Resistant Acute Lymphoblastic Leukemia; Refractory Acute Lymphoblastic Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleNanjing IASO Biotechnology Co.,…Phase 2

Eque-cel CAR-T Therapy (Eque-cel CAR-T Therapy)

AL Amyloidosis · AL Amyloidosis

#ALAmyloidosis#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 3Status Recruiting
CGTLimited DatastaleNanoscope Therapeutics Inc.Phase 2

Gene Therapy product-MCO-010 (Gene Therapy product-MCO-010)

Retinitis Pigmentosa; Retinitis · Retinitis Pigmentosa

#RetinitisPigmentosa#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastaleMiltenyi Biomedicine GmbHPhase 1

MB-CART19.1 Cellular Therapy (MB-CART19.1 Cellular Therapy)

Primary Central Nervous System (CNS) Lymphoma; Secondary Central Nervous System Lymphoma · Primary Central Nervous System (CNS) Lym

#PrimaryCentralNervousSystemCNSLy#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 3Status Recruiting
CGTLimited DatastaleOrchard TherapeuticsPhase 2

OTL-200 Gene Therapy (OTL-200 Gene Therapy)

Lysosomal Storage Disease; Metachromatic Leukodystrophy · Lysosomal Storage Disease

#LysosomalStorageDisease#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 3Status Active
CGTLimited DatastaleNeoImmuneTechPhase 1

CAR T-cell therapy (CAR T-cell therapy)

Large B-cell Lymphoma · Large B-cell Lymphoma

#LargeB-cellLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Active
CGTLimited DatastaleNanoscope Therapeutics Inc.Phase 2

Gene Therapy product:vMCO-I (Gene Therapy product:vMCO-I)

Retinitis Pigmentosa; Retinal Diseases · Retinitis Pigmentosa

#RetinitisPigmentosa#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Active
CGTLimited DatastaleTcelltech Inc.Phase 1

In Vivo CAR-T Therapy (In Vivo CAR-T Therapy)

Graves' Disease · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleMinicirclePhase 1

Injectable Plasmid Klotho Gene Therapy (Injectable Plasmid Klotho Gene Therapy)

Healthy Adults · Healthy Adults

#HealthyAdults#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Preclinical

Intrathecal and intravenous LV gene therapy (Intrathecal and intravenous LV gene therapy)

Metachromatic Leukodystrophy (MLD) · Metachromatic Leukodystrophy (MLD)

#MetachromaticLeukodystrophyMLD#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
CGTAAVLimited DatastalePfizerPhase 3

PF-07055480 (PF-07055480, PF-07055480 (giroctocogene fitelparovec): Recombinant AAV2/6 Human Factor VIII Gene Therapy, giroctocogene fitelparovec)

Hemophilia A · Hemophilia A

#HemophiliaA#CGT#Phase3#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
CGTLimited DatastaleSeoul National University Hospi…Phase 2

SNUH-CD19-CAR-T (SNUH-CD19-CAR-T)

Very High Risk Acute Lymphoblastic Leukemia; CD19 CAR-T Therapy · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleTargeted Genetics CorporationPhase 2

tgAAC94 gene therapy vector (tgAAC94 gene therapy vector)

Arthritis, Rheumatoid; Arthritis, Psoriatic · Arthritis, Rheumatoid

#ArthritisRheumatoid#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Active
CGTLimited DatastaleShanghai Cell Therapy Group Co.…Phase 1

αPD1-MSLN-CAR T cells (αPD1-MSLN-CAR T cells)

Colorectal Cancer; Ovarian Cancer · Non-small-cell Lung Cancer

#Non-small-cellLungCancer#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Active
CGTLimited DatastaleShanghai AbelZeta Ltd.Phase 1

A-CAR028 (A-CAR028)

Acute Myeloid Leukemia (AML); CAR-T Cell Therapy · Acute Myeloid Leukemia (AML)

#AcuteMyeloidLeukemiaAML#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTAAVLimited DatastaleREGENXBIO Inc.Phase 2

AAV directed hLDLR gene therapy (AAV directed hLDLR gene therapy)

Homozygous Familial Hypercholesterolemia (HoFH) · Homozygous Familial Hypercholesterolemia

#HomozygousFamilialHypercholester#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
CGTAAVLimited DatastaleMark TuszynskiPhase 1

AAV2-BDNF Gene Therapy (AAV2-BDNF Gene Therapy)

Alzheimer's Disease; Mild Cognitive Impairment · Alzheimer's Disease

#AlzheimersDisease#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTAAVLimited DatastaleMeiraGTx, LLCPhase 2

AAV2-hAQP1 (AAV2-hAQP1)

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Paroti… · Grade 2 and 3 Late Xerostomia Caused by

#Grade2and3LateXerostomiaCausedby#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active

2 / 6 pages

← PreviousNext →